Results 11 to 20 of about 12,165 (179)
Cutaneous Mucormycosis Clinically Mimicking Necrotizing Fasciitis in a Patient Without Active Immunosuppression. [PDF]
Clin Case RepABSTRACT Cutaneous mucormycosis is a rare invasive fungal infection caused by fungi of the order Mucorales. Although it classically occurs in immunocompromised hosts, traumatic or minor cutaneous inoculation may result in infection even in patients without active immunosuppression.
İnan AÖ +5 more
europepmc +2 more sources
Infectious Disease Clinics of North America, 2021 Mucormycosis is a rare but aggressive fungal disease that mainly affects patients with poorly controlled diabetes mellitus and those who are severely immunocompromised, including patients with hematological malignancies and solid organ transplant recipients. Early recognition of infection is critical for treatment success, followed by prompt initiation
Julie M, Steinbrink, Marisa H, Miceli
openaire +5 more sources
The Laryngoscope, 1977 AbstractThree cases of mucormycosis are presented; two with unusual aspects: One with previously unreported involvement of the mandible, and one presenting as a cavernous sinus thrombosis.Review of the literature reveals a limited number of survivors.
L, Eisenberg, T, Wood, R, Boles
openaire +2 more sources
Key molecules of Mucorales for COVID-19-associated mucormycosis: a narrative review
Journal of Bio-X Research, 2022 Mucormycosis is a lethal human disease caused by fungi of the order Mucorales. Mucormycosis is caused by fungi mainly belonging to the genera Mucor, Rhizopus, and Lichtheimia, all of which belong to the order Mucorales.
Priyanka Baberwal +3 more
doaj +1 more source
Autopsy Case Reports, 2023 Mucormycosis is a life-threatening fungal infection caused by mucormycetes, fungi of the Mucorales order.1 Rhino-orbital-cerebral involvement is the most common form of invasive mucormycosis. However, gastrointestinal (GI) mucormycosis cases have increased in the last two to three decades.2 Involvement of the GI tract in invasive mucormycosis is seen ...
Sourav Bhowmik +3 more
openaire +3 more sources
Effectiveness of COVID-19 Vaccination against COVID -associated Mucormycosis [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Coronavirus Disease-2019 (COVID-19) infections may be associated with a wide range of opportunistic bacterial and fungal co-infections. Both Aspergillus and Candida have been reported as the main fungal pathogens for co-infection in people ...
Rohit Mahla, Saurabh Shrivastava
doaj +1 more source
Mucormycosis following COVID19: clinical case and literature review [PDF]
Клиническая микробиология и антимикробная химиотерапия, 2021 Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%.
Khostelidi S.N. +7 more
doaj +1 more source
COVID19 associated mucormycosis: A review
Journal of Family Medicine and Primary Care, 2022 Mucormycosis, a rare fungal disease has emerged as a new epidemic in India, during the CoronaVirus Disease 2019 (COVID-19) pandemic. Mucormycosis is caused by the mucormycetes group of molds. Immunocompromised states such as diabetes, chronic steroid use,
Priyadharsini R Palanisamy +1 more
doaj +1 more source
A short review on black fungal mucormycosis accompanied by Post-SARS-CoV-2
Journal of the Scientific Society, 2023 Many people who have recovered from coronavirus disease 2019 (COVID-19) have recently been diagnosed with black fungus – or mucormycosis – disease. Rhino-orbital mucormycosis is becoming more common in people with COVID-19, particularly in India.
Abhishek Lachyan +3 more
doaj +1 more source
Journal of Fungi, 2018 Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in addition to amphotericin B products, to our armamentarium against mucormycosis, many uncertainties remain for the management of this uncommon opportunistic infection, as there are no data from prospective randomized clinical trials to guide therapy.
Nikolaos V. Sipsas +3 more
openaire +4 more sources